Fineline Cube

Follow:
14437 Articles
Ascentage Pharma's Oncology Drugs Lisaftoclax and Olverembatinib Gain CSCO Guidelines Inclusion
CompanyDrug

Ascentage Pharma’s Oncology Drugs Lisaftoclax and Olverembatinib Gain CSCO Guidelines Inclusion

Gan & Lee's GZR102 Receives NMPA Clinical Trial Clearance for Type 2 Diabetes
CompanyDrug

Gan & Lee’s GZR102 Receives NMPA Clinical Trial Clearance for Type 2 Diabetes

China's Medical Insurance Payment Reform Achieves Nationwide Coverage, Faces Challenges Ahead
Policy / Regulatory

China’s Medical Insurance Payment Reform Achieves Nationwide Coverage, Faces Challenges Ahead

Regeneron's Eylea HD Receives FDA Complete Response Letter Despite Priority Review
CompanyDrug

Regeneron’s Eylea HD Receives FDA Complete Response Letter Despite Priority Review

Hengrui Gains NMPA Approval for Phase III Study of SHR-8068 in PD-L1 Negative NSCLC
CompanyDrug

Hengrui Gains NMPA Approval for Phase III Study of SHR-8068 in PD-L1 Negative NSCLC

Kelun-Biotech Gains FDA Clearance for Phase I Trial of ADC SKB518
CompanyDrug

Kelun-Biotech Gains FDA Clearance for Phase I Trial of ADC SKB518

Grand Pharma's GPN02006 Shows Promising HCC Diagnostic Results in Trial
CompanyDrug

Grand Pharma’s GPN02006 Shows Promising HCC Diagnostic Results in Trial

Shanghai Operation Robot Secures RMB 100 Million Series C Funding for AI-Driven Surgical Robot Development
CompanyDeals

Shanghai Operation Robot Secures RMB 100 Million Series C Funding for AI-Driven Surgical Robot Development

Novo Nordisk Partners with JD Healthcare to Advance Obesity and Diabetes Management
CompanyDeals

Novo Nordisk Partners with JD Healthcare to Advance Obesity and Diabetes Management

Novo Nordisk's Wegovy Gets NMPA Label Update for Cardiovascular Risk Reduction
CompanyDrug

Novo Nordisk’s Wegovy Gets NMPA Label Update for Cardiovascular Risk Reduction

Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment
CompanyMedical Device

Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment

Rona Therapeutics Wins NMPA IND Approval for siRNA Hypertension Drug RN1871
CompanyDrug

Rona Therapeutics Wins NMPA IND Approval for siRNA Hypertension Drug RN1871